Association between neonatal care practices and efficacy of exogenous human surfactant: results of a bicenter randomized trial.
M Hallman, T A Merritt, K Bry...
https://pubmed.ncbi.nlm.nih.gov/8441558Completed
Phase 3
Age: 0 - 1Year
All Genders
ID00000570
Led by National Heart, Lung, and Blood Institute (NHLBI) · Updated on 2013-12-13
N/A
Participants Needed
N/A
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
To determine if surfactant administration at birth in infants at high risk for respiratory distress syndrome (RDS) modified the clinical course of the syndrome.
CONDITIONS
Official Title
Human Surfactant Treatment of Respiratory Distress Syndrome Bicenter Trial
Who Can Participate
Age: 0 - 1Year
All Genders
Eligibility Criteria
You may qualify if you...
Boy and girl preterm infants 24-29 weeks of gestational age and 500-1400 grams birthweight.
You will not qualify if you...
History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety
Trial Site Locations
Site Locations not provided
Location information for this trial is currently unavailable.
How is the study designed?
Study Type
INTERVENTIONAL
Masking
N/A
Allocation
RANDOMIZED
Model
N/A
Primary Purpose
PREVENTION
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here